Table Of Contents
1 Introduction 10
1.1 Objectives Of The Study 10
1.2 Market Definition 10
1.3 Overview Of North America Pdx Models Market 10
1.4 Currency And Pricing 11
1.5 Limitation 11
1.6 Markets Coveredss 11
2 Market Segmentation 13
2.1 Markets Covered 13
2.2 Geographic Scope 14
2.3 Years Considered For The Study 14
2.4 Currency And Pricing 15
2.5 Research Methodology 16
2.6 Primary Interviews With Key Opinion Leaders 19
2.7 Secondary Sources 20
2.8 Assumptions 20
3 Market Overview 21
3.1 Drivers 23
3.1.1 Rising Number Of Pharmaceutical R&D Activities In Cancer Research 23
3.1.2 Pdx Models Offer Advantages As Compared With The Classic Approach 25
3.1.3 Rising Need For Personalized Medicine 26
3.1.4 Increasing Support For Cancer Research Activities From Government And Non-Government Organization 26
3.2 Restraints 27
3.2.1 High Cost Of Pdx Models 27
3.2.2 Strict Regulation With Respect To The Utilization Of Animal Models In Cancer Research 27
3.3 Opprtunities 28
3.3.1 Increasing Demand For Humanized Pdx Models 28
3.4 Challenges 29
3.4.1 Limitations Of Pdx Models 29
4 Executive Summary 30
5 Premium Insights 32
6 North America Pdx Models Market, By Type 35
6.1 Overview 36
6.2 Mice Models 38
6.3 Rat Models 39
7 North America Pdx Models Market, By Tumor Type 40
7.1 Overview 41
7.2 Gastrointestinal Tumor Models 43
7.3 Gynecological Tumor Models 44
7.4 Respiratory Tumor Models 45
7.5 Urological Tumor Models 46
7.6 Hematological Tumor Models 47
7.7 Others 48
8 North America Pdx Models Market, By Application 49
8.1 Overview 50
8.2 Preclinical Drug Development And Oncology Research 52
8.3 Biomarker Analysis 53
9 North America Pdx Models Market, By End User 54
9.1 Overview 55
9.2 Contract Research Organizations 57
9.3 Pharmaceutical And Biotechnology Companies 58
9.4 Academic And Research Institutions 59
10 North America Pdx Models Market, By Geography 60
10.1 North America 60
10.1.1 U.S. 69
10.1.2 Canada 71
10.1.3 Mexico 73
11 North America Pdx Models Market, Company Landscape 75
11.1 Company Share Analysis; North America 75
12 Company Profiles 76
12.1 Charles River 76
12.1.1 Company Overview 76
12.1.2 Revenue Analysis 76
12.1.3 Company Share Analysis 77
12.1.4 Product Portfolio 77
12.1.5 Recent Developments 77
12.2 Crown Bioscience Inc. (Subsidiary Of Jsr Corporation) 78
12.2.1 Company Overview 78
12.2.2 Geographic Presence 78
12.2.3 Company Share Analysis 79
12.2.4 Product Portfolio 79
12.2.5 Recent Developments 80
12.3 Champion Oncology, Inc 81
12.3.1 Company Overview 81
12.3.2 Revenue Analysis 81
12.3.3 Company Share Analysis 82
12.3.4 Product Portfolio 82
12.3.5 Recent Developments 82
12.4 Aragen Bioscience (Subsidiary Of Gvk Biosciences Private Limited) 83
12.4.1 Company Overview 83
12.4.2 Product Portfolio 83
12.4.3 Recent Developments 83
12.5 Creative Animodel 84
12.5.1 Company Overview 84
12.5.2 Product Portfolio 84
12.5.3 Recent Developments 84
12.6 Epo Berlin-Buch Gmbh 85
12.6.1 Company Overview 85
12.6.2 Product Portfolio 85
12.6.3 Recent Developments 85
12.7 Europdx 86
12.7.1 Company Overview 86
12.7.2 Geographical Presence 86
12.7.3 Product Portfolio 87
12.7.4 Recent Developments 87
12.8 Hera Biolabs 88
12.8.1 Company Overview 88
12.8.2 Product Portfolio 88
12.8.3 Recent Developments 88
12.9 Horizon Discovery Group Plc 89
12.9.1 Company Overview 89
12.9.2 Revenue Analysis 89
12.9.3 Product Portfolio 90
12.9.4 Recent Developments 90
12.10 Mi Bioresearch Inc 91
12.10.1 Company Overview 91
12.10.2 Product Portfolio 91
12.10.3 Recent Developments 91
12.11 Oncodesign 92
12.11.1 Company Overview 92
12.11.2 Revenue Analysis 92
12.11.3 Product Portfolio 93
12.11.4 Recent Developments 93
12.12 Pharmatest Services Ltd 94
12.12.1 Company Overview 94
12.12.2 Geographic Presence 94
12.12.3 Product Portfolio 95
12.12.4 Recent Developments 95
12.13 The Jackson Laboratory 96
12.13.1 Company Overview 96
12.13.2 Revenue Analysis 96
12.13.3 Product Portfolio 97
12.13.4 Recent Developments 97
12.14 Urolead 98
12.14.1 Company Overview 98
12.14.2 Product Portfolio 98
12.14.3 Recent Developments 98
12.15 Wuxi Apptec 99
12.15.1 Company Overview 99
12.15.2 Geographic Presence 99
12.15.3 Product Portfolio 100
12.15.4 Recent Developments 100
12.16 Xentech 101
12.16.1 Company Overview 101
12.16.2 Product Portfolio 101
12.16.3 Recent Developments 101
13 Related Reports 102